Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in SXTP held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Kathmere Capital Management, LLC | 145K | $253K | — | 17.938% | 0.02% |
| 2 | UBS Group AG | 31K | $55K | +2028.0% | 3.894% | 0.00% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 16K | $29K | +30.9% | 2.020% | 0.00% |
| 4 | BARCLAYS PLC | 2K | $3K | +22.7% | 0.230% | 0.00% |
| 5 | ADVISOR GROUP HOLDINGS, INC. | 25 | $43 | -75.0% | 0.003% | 0.00% |
| 6 | TWIN PEAKS WEALTH ADVISORS, LLC | 8 | $14 | — | 0.001% | 0.00% |
| 7 | CITIGROUP INC | 1 | $2 | — | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in SXTP — a direct measure of their conviction.
Filings activity in SXTP during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 7 | +0.0% | 30.99% | +28.93 pp | $0M | +1408% |
| Q4 2025 | 7 | +17% | 2.06% | 0.27 pp | $0M | 12% |
| Q3 2025 | 6 | +0.0% | 2.33% | 1.00 pp | $0M | 30% |
| Q2 2025 | 6 | 14% | 3.33% | 1.67 pp | $0M | 33% |
| Q1 2025 | 7 | 22% | 5.00% | 11.54 pp | $0M | 70% |
| Q4 2024 | 9 | +13% | 16.54% | +14.22 pp | $0M | +613% |
| Q3 2024 | 8 | 27% | 2.32% | 4.26 pp | $0M | 65% |
| Q2 2024 | 11 | — | 6.58% | — | $0M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying SXTP stock.
Based on Q1 2026 13F filings, institutional ownership of 60 Degrees Pharmaceuticals, Inc. stands at 31.0%, held across 7 reporting institutions.
Kathmere Capital Management, LLC is the largest reported institutional holder of SXTP, with approximately 144,683 shares worth $0.00B as of Q1 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of SXTP.
Our composite Smart Money Score for SXTP is 47 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
3 institutions opened new positions in SXTP during Q1 2026, while 3 fully exited. 3 added to existing positions and 1 trimmed.
SXTP institutional ownership rose by 28.93 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 100.0% of all reported 13F value in SXTP, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
60 Degrees Pharmaceuticals, Inc. (SXTP) Institutional Ownership